Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy
- 1 August 2017
- Vol. 51, 102-106
- https://doi.org/10.1016/j.seizure.2017.07.015
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81471316, 81671283)
- Medical Health Sci-tech Program of ZheJiang Province (2017RC004)
This publication has 32 references indexed in Scilit:
- Linkage Disequilibrium between Polymorphisms of ABCB1 and ABCC2 to Predict the Treatment Outcome of Malaysians with Complex Partial Seizures on Treatment with Carbamazepine Mono-Therapy at the Kuala Lumpur HospitalPLOS ONE, 2013
- Five-Vertebrate ChIP-seq Reveals the Evolutionary Dynamics of Transcription Factor BindingScience, 2010
- Polymorphism of the MDR1/ABCB1 C3435T drug‐transporter and resistance to anticonvulsant drugs: A meta‐analysisEpilepsia, 2009
- Regulation of Hepatocyte Nuclear Factor 4α-mediated TranscriptionDrug Metabolism and Pharmacokinetics, 2008
- A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate SpecificityScience, 2007
- IN VITRO CHARACTERIZATION OF LAMOTRIGINEN2-GLUCURONIDATION AND THE LAMOTRIGINE-VALPROIC ACID INTERACTIONDrug Metabolism and Disposition, 2006
- 10-Hydroxycarbazepine Serum Concentration-to-Oxcarbazepine Dose RatioTherapeutic Drug Monitoring, 2005
- An Association of UDP-Glucuronosyltransferase 2B7 C802T (His268Tyr) Polymorphism with Bladder Cancer in Benzidine-Exposed Workers in ChinaToxicological Sciences, 2005
- N-Glucuronidation of Carbamazepine in Human Tissues Is Mediated by UGT2B7Journal of Pharmacology and Experimental Therapeutics, 2004
- Expression and Cellular Distribution of Multidrug Resistance–related Proteins in the Hippocampus of Patients with Mesial Temporal Lobe EpilepsyEpilepsia, 2004